GPR158 and esophageal squamous cell carcinoma: Moreover, alterations in GPR158 methylation have been observed in esophageal squamous cell carcinoma and melanoma (Oka et al., 2009; Koroknai et al., 2020; Fu et al., 2022), indicating that GPR158 may serve as a potential risk marker beyond NDs.